PPP4R3A

Serine/threonine-protein phosphatase 4 regulatory subunit 3A · Q6IN85 · PPP4R3A on Sugi Atlas →

0 patent compounds predicted against PPP4R3A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PPP4R3A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis PHASE4COMPLETED
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Open-label Study on Treatment of Primary Aldosteronism With Everolimus PHASE2COMPLETED
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients PHASE1/PHASE2WITHDRAWN
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery PHASE2COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Immune Signature of Palmoplantar Pustulosis nanCOMPLETED
NGS in Gallbladder Cancer and Response to Treatment nanRECRUITING
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease nanUNKNOWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People nanCOMPLETED
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Severe Insulin Resistance in Patients With Type 2 Diabetes nanCOMPLETED
Partial PTEN Deletion in Breast Cancer nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
CircularRNA-microRNA-mRNA Regulatory Axis in IVF nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a PPP4R3A binder may also engage these)

ProteinNameSimilarity
Q6P2K6 1.000 Q6P2K6 →
Q6INN7 1.000 Q6INN7 →
Q922R5 1.000 Q922R5 →
Q7ZX60 1.000 Q7ZX60 →
Q6DFT3 1.000 Q6DFT3 →
Q5SP90 1.000 Q5SP90 →
Q801Q7 1.000 Q801Q7 →
Q4S6U8 1.000 Q4S6U8 →
Q5MIZ7 0.998 Q5MIZ7 →
Q9VFS5 0.992 Q9VFS5 →
Q8RW96 0.989 Q8RW96 →
B3NU52 0.988 B3NU52 →
Q8CDM8 0.987 Q8CDM8 →
Q9LU89 0.987 Q9LU89 →
A4FV68 0.987 A4FV68 →
O35638 0.986 O35638 →
Q9Y6D5 0.986 Q9Y6D5 →
Q8N3U4 0.986 Q8N3U4 →
B4Q034 0.986 B4Q034 →
Q66L58 0.986 Q66L58 →
Q9SV41 0.986 Q9SV41 →
B3MS75 0.986 B3MS75 →
Q84ZC0 0.985 Q84ZC0 →
Q9D3E6 0.985 Q9D3E6 →
Q8WVM7 0.985 Q8WVM7 →
O04376 0.985 O04376 →
ARFGEF1 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 0.985 landscape →
Q16537 0.985 Q16537 →
Q9DGN0 0.985 Q9DGN0 →
B4I0W6 0.985 B4I0W6 →